EMA and FDA create pharmacovigilance 'cluster' (PMLive, 20 February 2014)

24 Feb 2014


The European Medicines Agency (EMA) and its US counterpart the Food and Drug Administration (FDA) have resolved to create a 'pharmacovigilence cluster', involving monthly meetings to improve information-sharing between the two organisations.

Full article


Share this story